ARAF

ARAF

Target · Serine/threonine kinase

ARAF A-Raf proto-oncogene, serine/threonine kinase · Serine/threonine-protein kinase A-Raf

ARAF (A-Raf proto-oncogene, serine/threonine kinase, also known as A-Raf or ARAF1) is a member of the RAF family of serine/threonine protein kinases. It acts as a positive regulator of myogenic differentiation and is linked to apoptosis and TOR signalling. Browse Assay Genie's current range of ARAF research reagents below, or read on for the biology behind the target.

Plasma membrane kinaseRAF family kinaseHigh grade glioma biomarker
606 aa
Protein length
~68 kDa
Molecular weight
Xp11.3
Gene locus
EC 2.7.11.1
Enzyme class
Target information

What is ARAF (a-Raf proto-oncogene, serine/threonine kinase)?

ARAF encodes a serine/threonine-protein kinase that enables protein serine/threonine kinase activity. UniProt annotates it as a positive regulator of myogenic differentiation: it induces cell cycle arrest, the expression of myogenin and other muscle-specific proteins, and myotube formation. Studies of the A-Raf protein therefore sit naturally within muscle cell biology and differentiation research.

The A-Raf protein belongs to the protein kinase superfamily, in the TKL Ser/Thr protein kinase family and the RAF subfamily. HGNC places the ARAF gene in the group of mitogen-activated protein kinase kinase kinases, within the RAF family. According to NCBI Gene, A-Raf is located in the plasma membrane and is involved in the negative regulation of the apoptotic process, the regulation of TOR signalling and the regulation of protein metabolic process.

The gene was previously named v-raf murine sarcoma 3611 viral oncogene homolog 1, and ARAF1 is a recorded alias alongside A-Raf. NCBI Gene also describes ARAF as a biomarker of high grade glioma, which makes it of interest in cancer research. Mouse and rat both carry an orthologous Araf gene, allowing the kinase to be studied in common rodent models.

Myogenic differentiation

ARAF positively regulates myogenic differentiation, inducing cell cycle arrest, myogenin expression and myotube formation, so it is relevant to studies of muscle development.

Apoptosis regulation

NCBI Gene lists ARAF as involved in negative regulation of the apoptotic process, making it a subject for cell survival research.

TOR signalling

ARAF is implicated in the regulation of TOR signalling and of protein metabolic process, supporting work on kinase control of cell metabolism.

Glioma biomarker research

ARAF is described as a biomarker of high grade glioma, giving it relevance to neuro-oncology and tumour characterisation studies.

Background

ARAF frequently asked questions

What does ARAF do?

ARAF is a serine/threonine protein kinase of the RAF family. UniProt describes it as a positive regulator of myogenic differentiation, inducing cell cycle arrest, myogenin expression and myotube formation. NCBI Gene also links it to negative regulation of apoptosis and to TOR signalling.

What other names does ARAF go by?

ARAF is also written A-Raf or ARAF1. Its full HGNC name is A-Raf proto-oncogene, serine/threonine kinase, and UniProt calls the product serine/threonine-protein kinase A-Raf. An earlier gene name was v-raf murine sarcoma 3611 viral oncogene homolog 1.

Is ARAF conserved in mouse and rat, and is it linked to disease?

Mouse and rat each have an orthologous gene named Araf. NCBI Gene describes ARAF as a biomarker of high grade glioma. Check the datasheet of any product for its validated reactivity before using it in a given species.

Explore

Related targets

Other RAF family kinases, MAP kinase pathway components and myogenic differentiation markers with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P10398; product specifications from Assay Genie datasheets.

ARAF Product listing